Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice. | Cancer Cell Int | 2022 | 35033090 | PubTator, text mining | PubMed |
| Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association. | Nat Commun | 2022 | 35013211 | PubTator, text mining | PubMed |
| Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance. | Int J Biol Sci | 2022 | 35002522 | PubTator, text mining | PubMed |
| Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation. | Elife | 2022 | 34984976 | PubTator, text mining | PubMed |
| Developmental and Injury-induced Changes in DNA Methylation in Regenerative versus Non-regenerative Regions of the Vertebrate Central Nervous System. | BMC Genomics | 2022 | 34979916 | PubTator, text mining | PubMed |
| The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma. | J Cancer | 2022 | 34976182 | PubTator, text mining | PubMed |
| A genome-wide scan to locate regions associated with familial vesicoureteral reflux. | Exp Ther Med | 2022 | 34976134 | PubTator, text mining | PubMed |
| PPDPF Promotes the Progression and acts as an Antiapoptotic Protein in Non-Small Cell Lung Cancer. | Int J Biol Sci | 2022 | 34975328 | PubTator, text mining | PubMed |
| Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4. | Int J Biol Sci | 2022 | 34975318 | PubTator, text mining | PubMed |
| Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer. | ISME J | 2022 | 34972816 | PubTator, text mining | PubMed |
| Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5. | Toxicol Appl Pharmacol | 2022 | 34919946 | PubTator, text mining | PubMed |
| Insights into roles of METTL14 in tumors. | Cell Prolif | 2022 | 34904301 | PubTator, text mining | PubMed |
| Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. | Mol Ther | 2022 | 34793975 | PubTator, text mining | PubMed |
| Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling. | J Gynecol Oncol | 2022 | 34783205 | PubTator, text mining | PubMed |
| PDGF-BB induces PRMT1 expression through ERK1/2 dependent STAT1 activation and regulates remodeling in primary human lung fibroblasts. | Cell Signal | 2022 | 34774382 | PubTator, text mining | PubMed |
| Shared and specific functions of Arfs 1-5 at the Golgi revealed by systematic knockouts. | J Cell Biol | 2022 | 34749397 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition and its transcription factors. | Biosci Rep | 2022 | 34708244 | PubTator, text mining | PubMed |
| An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. | Cell Chem Biol | 2022 | 34672954 | PubTator, text mining | PubMed |
| Protein arginine N-methyltransferase 1 gene polymorphism is associated with proliferative diabetic retinopathy in a Japanese population. | Acta Diabetol | 2022 | 34648085 | PubTator, text mining | PubMed |
| FOXOs: masters of the equilibrium. | FEBS J | 2022 | 34610198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=43